MANNKIND CORP Income Taxes Paid
MANNKIND CORP (MNKD) reported Income Taxes Paid of $816.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-05
- MANNKIND CORP income taxes paid, net for the quarter ending 2026-06-30 was $753.00K, a 13.35% decline year-over-year.
- MANNKIND CORP income taxes paid, net for the quarter ending 2026-03-31 was $63.00K, a 69.57% decline year-over-year.
- MANNKIND CORP income taxes paid, net for the quarter ending 2025-12-31 was $549.00K, a 76.14% decline year-over-year.
- MANNKIND CORP income taxes paid, net for the quarter ending 2025-09-30 was $80.00K, a 66.10% decline year-over-year.
- MANNKIND CORP income taxes paid, net for fiscal 2025 was $1.71M, a 60.00% decline from fiscal 2024.
- MANNKIND CORP income taxes paid, net for fiscal 2024 was $4.26M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $753.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $816.00K 10-Q · filed 2026-08-05 | $1.36M derived: sum of 3 quarters · filed 2026-08-05 | $1.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $63.00K 10-Q · filed 2026-05-06 | $612.00K derived: sum of 2 quarters · filed 2026-05-06 | $692.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.56M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $629.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.50M derived: sum of 3 quarters · filed 2026-08-05 | $1.71M 10-K · filed 2026-02-26 |
| 2025-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $949.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.16M 10-Q · filed 2025-11-05 | $3.46M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $869.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.08M 10-Q · filed 2026-08-05 | $3.38M derived: sum of 3 quarters · filed 2026-08-05 | $3.61M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $207.00K 10-Q · filed 2026-05-06 | $2.51M derived: sum of 2 quarters · filed 2026-05-06 | $2.74M derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.54M derived: sum of 2 quarters · filed 2026-02-26 | $4.26M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.96M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $1.73M 10-Q · filed 2025-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |